Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
inactivated influenza vaccine (3 trials)
bi 1361849 (1 trial)
human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil) (1 trial)
venezuelan equine encephalitis virus dna vaccine (1 trial)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Influenza, Human (Phase 4)
Lung Neoplasms (Phase 2)
Trials (6 total)
Trial APIs (4 total)